• ASTRO 2024 Highlights: Dr. Kristin Higgins on Optimal Sequence for SCLC Therapies

    At the 2024 Annual Meeting of the American Society for Radiation Oncology (ASTRO), the second interim analysis of the Phase III NRG-LU005 trial revealed the importance of timing when combining immunotherapy with chemoradiotherapy for limited-stage small cell lung cancer (SCLC). The findings showed no significant survival benefits for patients who received atezolizumab concurrently with chemoradiotherapy…

  • CSCO 2024 | Dr. Ruihua Xu: Patient-Centered Approach to Innovating the Future of Cancer Treatment

    From September 25 to 29, 2024, the 27th National Clinical Oncology Conference and 2024 CSCO Annual Meeting, organized by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, were held in Xiamen. The theme of this year’s conference was “Patient-Centered, Sharing the Future,” bringing together key research advancements and…

  • CUA 2024 Presents: Advancing Kidney-Sparing Strategies for UTUC

    Radical nephroureterectomy (RNU) remains the gold standard treatment for upper tract urothelial carcinoma (UTUC). However, some patients with a solitary kidney or insufficient renal reserve may require alternative approaches to preserve kidney function. In recent years, advancements in systemic drug therapy and various endoscopic focal treatment techniques have provided kidney-sparing options for such patients. Nonetheless,…

  • ESMO 2024 Pioneers: Dr. Filippo Pietrantonio on the Cutting Edge of Upper GI Cancer Research

    As one of the world’s largest and most academically prestigious clinical oncology conferences, the 2024 European Society for Medical Oncology (ESMO) conference, held from September 13 to 17 in Barcelona, drew global attention. The conference revealed several important clinical study results in upper gastrointestinal tumors. Dr. Filippo Pietrantonio, an oncologist from the National Cancer Institute…

  • Conference Chairman Dr. Han Liang Discusses the Growth Path for Oncologic Surgeons and the Future of Surgical Oncology

    From October 18 to 19, 2024, the CACA Gastric Cancer Integration Conference was held in Wuhan, bringing together multidisciplinary experts from both domestic and international fields to focus on the frontiers, standards, and progress in gastric cancer diagnosis and treatment. During the conference, Oncology Frontier had the opportunity to interview the conference chairman, Dr. Han…

  • Dr. Ying Cheng: New Approaches in Radiotherapy and Immunotherapy, Leading a New Era in the Treatment of Unresectable Lung Cancer

    Radiotherapy combined with immunotherapy has become a significant focus in the treatment of unresectable lung cancer, but many key clinical questions remain unresolved. Establishing a consensus is crucial to guide standardized clinical practice. To address these needs, Academician Jinming Yu from Shandong Cancer Hospital, Dr. Ying Cheng from Jilin Cancer Hospital, and Dr. Lian’an Chen…

  • Prof. Zefei Jiang: Fostering SGBCC-CSCO Cooperation and Amplifying China’s Voice

    From October 19-20, 2024, the first stop of the “St. Gallen Breast Cancer Conference China Tour” was held in Nanjing. This series of conferences is organized by the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), with support from the Beijing Xisike Clinical Oncology Research Foundation, the Beijing Kexin Medical Development…

  • Dr. Guangyu Liu: Redefining Beauty—Current Status and Future of Breast Reconstruction Techniques |16th Shanghai Breast Reconstruction Conference

    Breast cancer is one of the most common malignancies among women, and while treatment methods continue to improve, maintaining patients’ quality of life while extending their survival remains a key focus in the medical community. With the emergence of oncoplastic surgery (OPS) and fat grafting techniques, the post-operative quality of life for breast cancer patients…